The contrast in these results from postmortem sampling to the live patient data we present here suggests that there may not only be differences in the level of circulating blood CD4+BTLA+ versus their lung CD4+ T-cell sample sites, but also in the timing of the sample acquisition during the sepsis process. The gene discussed is BTLA; the disease is Sepsis.